Treatment of Chronic Granulomatous Disease–Related Pulmonary Aspergillus Infection in Late Pregnancy

• Published in: Open forum infectious diseases 2020-10, Vol.7 (10)
• Main Authors: Johnson, J A, Pearson, J C, Kubiak, D W, Dionne, B, Little, S E, Wesemann, D R
• Format: Article
• Language: English
• Subjects: Novel ID Cases
• ISSN: 2328-8957; 2328-8957
• DOI: 10.1093/ofid/ofaa447

Abstract Chronic granulomatous disease (CGD) is a primary immunodeficiency syndrome that results in increased risk for bacterial and fungal infections, as well as inflammatory/autoimmune complications. While CGD historically has been associated with early death in childhood, the life expectancy and morbidity of patients with CGD have greatly improved. Many patients with CGD now survive well into adulthood, and data on adult cohorts of patients with CGD have been published. However, reports of pregnancy management, complications, and outcomes for patients with CGD are sparse. In addition, management of invasive fungal infections, including use of newer triazole antifungals, during pregnancy has not been well described. We report a case of fungal lung infection in a pregnant woman with CGD, diagnosed during her second trimester, which was treated with multiple antifungal agents, including more than 12 weeks of isavuconazole therapy, resulting in resolution of infection and delivery of a healthy newborn at term.